The Kaplan–Meier analysis showed that CRC patients with high MFAP2 expression in tumor tissues had a lower overall survival rate than those with low MFAP2 expression (p = 0.020, Figure 2C). The gene discussed is MFAP2; the disease is colorectal carcinoma.